List of works - Ronald Vender

A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 24-Week Efficacy and Safety Results from a Randomised, Double-Blinded Trial

scientific article published on 02 September 2020

A Review of Drug-Drug Interactions for Biologic Drugs Used in the Treatment of Psoriasis

scientific article published on 01 September 2020

A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

scientific article

A consensus on acne management focused on specific patient features

scientific article

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

scientific article published on 28 October 2014

Acitretin Use in Dermatology.

scientific article published in September 2017

Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial

scientific article published on 20 December 2010

Adalimumab in the treatment of psoriasis: pooled efficacy and safety results from three pivotal studies.

scientific article published on September 2009

Alternative treatments for atopic dermatitis: a selected review.

scientific article

An Open Letter to Health Canada

scientific article published in May 2017

An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.

scientific article published on April 2011

Antihistamines in the treatment of dermatitis.

scientific article

Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada

scientific article published on May 2010

Biologic survival.

scientific article published on April 2009

Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology Clinical Practice

scientific article

Biosimilars for psoriasis: clinical studies to determine similarity.

scientific article published on 17 September 2016

Biosimilars for psoriasis: preclinical analytical assessment to determine similarity.

scientific article

Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

scientific article published on 13 May 2018

Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study

scientific article published on 10 March 2019

Clinical features of external genital warts

scientific article published on December 2013

Comparison of dermatologists' and nondermatologists' diagnostic accuracy for malignant melanoma

scientific article published on 01 July 2012

Cutaneous reaction to drugs used for erectile dysfunction: case report and review of the literature.

scientific article published on May 2006

Drug-induced lichenoid dermatitis with histopathologic features of mycosis fungoides in a patient with psoriasis

scientific article published on 01 November 2010

Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.

scientific article published on 21 October 2017

Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis.

scientific article published on 07 September 2016

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies.

scientific article published on 7 December 2017

Efficacy outcomes in patients using alefacept in the AWARE study

scientific article published on 01 December 2009

Erythema ab igne caused by laptop computer gaming--a case report

scientific article published on 01 June 2012

Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice ⬇️

scientific article published on November 1, 2012

Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.

scientific article published on 20 January 2015

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use

Innovative uses of imiquimod.

scientific article

Interleukin 17A: toward a new understanding of psoriasis pathogenesis

scientific article published on 18 March 2014

Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 can be Divided Into Inflammatory and Vascular Patterns

scientific article published on 12 November 2020

Management and treatment of pruritus.

scientific article published on February 2007

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.

scientific article

Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper

scientific article published on 05 June 2020

Managing external genital warts: practical aspects of treatment and prevention

scientific article published on December 2013

Miliarial gout (a new entity)

scientific article published on 01 January 2007

Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits

scientific article published on March 2014

Nail psoriasis and biologics.

scientific article

Newer approaches in topical combination therapy for acne

scientific article published on 01 October 2011

Occurrence of plantar pustular psoriasis during treatment with infliximab.

scientific article

Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis

scientific article published on 16 April 2019

Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice

scientific article published on 12 May 2020

Practical understanding of mean percent psoriasis area and severity index reduction for biologics.

scientific article published in November 2008

Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.

scientific article

Psoriasis patients' preference for an aerosol foam topical formulation

scientific article published on 03 May 2018

Public Engagement with Dermatology Contents on Facebook

scientific article published on 13 March 2015

Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study.

scientific article published in January 2011

Review of Systemic Treatment Options for Adult Atopic Dermatitis.

scientific article published on 15 September 2016

Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis

scientific article

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.

scientific article published on 20 September 2016

Sulfa or Sulfur? Clearing Things up

scientific article published on 01 March 2013

Survival of the fittest

scientific article published on 01 February 2018

Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome ⬇️

scientific article published on June 5, 2011

The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis

scientific article published on 31 August 2020

The Role of IL-17 in Papulopustular Rosacea and Future Directions

scientific article published on 12 August 2019

Therapeutic options for external genital warts

scientific article

Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.

scientific article published on January 2015

Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations ⬇️

scientific article published on November 1, 2011

Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early Look

scientific article

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

scientific article published on 01 April 2017

Undergraduate Dermatology Education in Canada: A National Survey.

scientific article

Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus

scientific article published on December 2013

Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial

scientific article published on 01 January 2006

Use of facebook as a tool for knowledge dissemination in dermatology.

scientific article published in September 2014

Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting.

scientific article published on September 2012

List of works by Ronald Vender

A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 24-Week Efficacy and Safety Results from a Randomised, Double-Blinded Trial

A Review of Drug-Drug Interactions for Biologic Drugs Used in the Treatment of Psoriasis

A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

A consensus on acne management focused on specific patient features

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

Acitretin Use in Dermatology.

Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial

Adalimumab in the treatment of psoriasis: pooled efficacy and safety results from three pivotal studies.

Alternative treatments for atopic dermatitis: a selected review.

An Open Letter to Health Canada

An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.

Antihistamines in the treatment of dermatitis.

Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada

Biologic survival.

Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology Clinical Practice

Biosimilars for psoriasis: clinical studies to determine similarity.

Biosimilars for psoriasis: preclinical analytical assessment to determine similarity.

Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study

Clinical features of external genital warts

Comparison of dermatologists' and nondermatologists' diagnostic accuracy for malignant melanoma

Cutaneous reaction to drugs used for erectile dysfunction: case report and review of the literature.

Drug-induced lichenoid dermatitis with histopathologic features of mycosis fungoides in a patient with psoriasis

Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.

Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis.

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies.

Efficacy outcomes in patients using alefacept in the AWARE study

Erythema ab igne caused by laptop computer gaming--a case report

Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice ⬇️

Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use

Innovative uses of imiquimod.

Interleukin 17A: toward a new understanding of psoriasis pathogenesis

Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 can be Divided Into Inflammatory and Vascular Patterns

Management and treatment of pruritus.

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.

Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper

Managing external genital warts: practical aspects of treatment and prevention

Miliarial gout (a new entity)

Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits

Nail psoriasis and biologics.

Newer approaches in topical combination therapy for acne

Occurrence of plantar pustular psoriasis during treatment with infliximab.

Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis

Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice

Practical understanding of mean percent psoriasis area and severity index reduction for biologics.

Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.

Psoriasis patients' preference for an aerosol foam topical formulation

Public Engagement with Dermatology Contents on Facebook

Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study.

Review of Systemic Treatment Options for Adult Atopic Dermatitis.

Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.

Sulfa or Sulfur? Clearing Things up

Survival of the fittest

Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome ⬇️

The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis

The Role of IL-17 in Papulopustular Rosacea and Future Directions

Therapeutic options for external genital warts

Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.

Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations ⬇️

Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early Look

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

Undergraduate Dermatology Education in Canada: A National Survey.

Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus

Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial

Use of facebook as a tool for knowledge dissemination in dermatology.

Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting.